Larvol Delta - Acumen-Pharmaceuticals-Announces-Journal-of-Prevention-of-Alzheimers-Disease-Publication-of-the-Companys-Phase-1-INTERCEPTAD-Study-Including-Target-Engagement-Dosing-Regimen-and-Safety-Findings

sabirnetug IV (ACU193 IV) - Acumen Pharma

https://www.globenewswire.com/news-release/2025/01/09/3007016/0/en/Acumen-Pharmaceuticals-Announces-Journal-of-Prevention-of-Alzheimer-s-Disease-Publication-of-the-Company-s-Phase-1-INTERCEPT-AD-Study-Including-Target-Engagement-Dosing-Regimen-and.html

Jan 9, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next